A detailed history of Sei Investments CO transactions in Biogen Inc. stock. As of the latest transaction made, Sei Investments CO holds 107,952 shares of BIIB stock, worth $15.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
107,952
Previous 105,351 2.47%
Holding current value
$15.8 Million
Previous $24.4 Million 14.32%
% of portfolio
0.03%
Previous 0.04%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $491,771 - $615,916
2,601 Added 2.47%
107,952 $20.9 Million
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $2.84 Million - $3.53 Million
14,900 Added 16.47%
105,351 $24.4 Million
Q1 2024

May 07, 2024

BUY
$212.02 - $267.71 $177,460 - $224,073
837 Added 0.93%
90,451 $19.5 Million
Q4 2023

Feb 14, 2024

SELL
$222.59 - $267.94 $485,691 - $584,645
-2,182 Reduced 2.38%
89,614 $23.2 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $135,515 - $152,951
535 Added 0.59%
91,796 $23.6 Million
Q2 2023

Aug 11, 2023

SELL
$275.25 - $318.06 $2.79 Million - $3.23 Million
-10,154 Reduced 10.01%
91,261 $26 Million
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $1.02 Million - $1.16 Million
3,983 Added 4.09%
101,415 $28.2 Million
Q4 2022

Feb 10, 2023

SELL
$252.44 - $306.72 $1.62 Million - $1.97 Million
-6,426 Reduced 6.19%
97,432 $27 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $1.41 Million - $1.95 Million
-7,264 Reduced 6.54%
103,858 $27.7 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $20.7 Million - $24.6 Million
-110,221 Reduced 49.8%
111,122 $22.6 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $6.32 Million - $7.96 Million
-32,617 Reduced 12.84%
221,343 $46.6 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $9.86 Million - $12.7 Million
44,012 Added 20.96%
253,960 $60.8 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $35.7 Million - $46.5 Million
126,096 Added 150.38%
209,948 $59.5 Million
Q2 2021

Aug 06, 2021

SELL
$259.0 - $414.71 $4.27 Million - $6.83 Million
-16,469 Reduced 16.42%
83,852 $29 Million
Q1 2021

May 12, 2021

BUY
$242.95 - $284.63 $282,064 - $330,455
1,161 Added 1.17%
100,321 $27.1 Million
Q4 2020

Feb 08, 2021

SELL
$236.26 - $355.63 $5.72 Million - $8.62 Million
-24,230 Reduced 19.64%
99,160 $24.3 Million
Q3 2020

Dec 04, 2020

SELL
$264.77 - $305.71 $745,062 - $860,267
-2,814 Reduced 2.23%
123,390 $35 Million
Q3 2020

Nov 06, 2020

BUY
$264.77 - $305.71 $234,056 - $270,247
884 Added 0.71%
126,204 $35.8 Million
Q2 2020

Aug 17, 2020

SELL
$258.66 - $342.55 $2.01 Million - $2.66 Million
-7,762 Reduced 5.83%
125,320 $33.6 Million
Q2 2020

Aug 11, 2020

BUY
$258.66 - $342.55 $1.8 Million - $2.39 Million
6,971 Added 5.53%
133,082 $38.4 Million
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $145,447 - $184,502
-541 Reduced 0.43%
126,111 $39.9 Million
Q4 2019

Feb 06, 2020

BUY
$220.06 - $304.07 $1.86 Million - $2.57 Million
8,462 Added 7.16%
126,652 $37.6 Million
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $2.58 Million - $2.9 Million
11,886 Added 11.18%
118,190 $27.3 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $2.37 Million - $2.62 Million
-10,827 Reduced 9.24%
106,304 $24.7 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $3.59 Million - $5.61 Million
-16,545 Reduced 12.38%
117,131 $27.5 Million
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $1.5 Million - $1.9 Million
5,394 Added 4.2%
133,676 $46.4 Million
Q3 2018

Nov 08, 2018

SELL
$293.51 - $383.83 $12.1 Million - $15.9 Million
-41,324 Reduced 24.36%
128,282 $45.3 Million
Q2 2018

Aug 03, 2018

BUY
$257.52 - $306.91 $2.4 Million - $2.86 Million
9,327 Added 5.82%
169,606 $49.2 Million
Q1 2018

May 11, 2018

SELL
$260.13 - $367.91 $44.8 Million - $63.3 Million
-172,152 Reduced 51.79%
160,279 $43.9 Million
Q4 2017

Feb 08, 2018

BUY
$307.64 - $344.58 $3.02 Million - $3.38 Million
9,809 Added 3.04%
332,431 $106 Million
Q3 2017

Nov 06, 2017

BUY
$281.15 - $329.69 $90.7 Million - $106 Million
322,622
322,622 $101 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.